SCHEMBL1287182

SCHEMBL1287182

CC(CC(C)C(=O)OC(C)(C)C)C(=O)NC(Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1

nearest known ligand 0.65

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL467973 0.92 PTPRB (0.71) PTPRB
SCHEMBL468246 0.91 PTPRB (0.66) PTPRB
SCHEMBL3926682 0.90 PTPRB (0.65) PTPRB
SCHEMBL680027 0.90 PTPRB (0.65) PTPRB
SCHEMBL680026 0.90 PTPRB (0.65) PTPRB
SCHEMBL679603 0.87 PTPRB (0.72) PTPRB
SCHEMBL679604 0.87 PTPRB (0.72) PTPRB
SCHEMBL21670804 0.84 PTPRB (0.70) PTPRB
SCHEMBL679639 0.84 PTPRB (0.70) PTPRB
SCHEMBL679638 0.84 PTPRB (0.70) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2624916-A2 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES Aerpio Therapeutics Inc. (US) 2013-08-14 EP claimed
WO-2012047966-A2 COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARIZATION AND RELATED DISEASES AKEBIA THERAPEUTICS INC. (US) 2012-04-12 WO claimed
EP-2967066-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES Aerpio Therapeutics Inc. (US) 2016-01-20 EP disclosed
WO-2014145068-A1 COMPOSITIONS, FORMULATIONS AND METHODS FOR TREATING OCULAR DISEASES AERPIO THERAPEUTICS INC. (US) 2014-09-18 WO disclosed